BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,406.70
0.57%
S&P ASX All Technology
3,915.30
0.60%
Brent Oil
72.59
0.19%
US Dollar vs AUD
1.54226
-0.15%
Bitcoin
93,641.79
1.82%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aclaris Therapeutics Inc (ACRS) Share Price

Aclaris Therapeutics Inc

Aclaris Therapeutics Inc (ACRS)

NASDAQ
3.63
-0.36
(-9.02%)
Closed 27 November 8:00AM
Delayed by 15 minutes
3.63
0.00
( 0.00% )
Pre Market: 8:11PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
3.63
Bid
3.60
Offer
4.21
Volume
83
0.00 Day's Range 0.00
0.77 52 Week Range 5.17
Market Cap
259.294M
Previous Close
3.63
Open
-
Last Trade
10
@
3.64
Last Trade Time
20:32:39
Financial Volume
-
VWAP
-
Average Volume (3m)
2,275,894
Shares Outstanding
71,430,942
Dividend Yield
-
PE Ratio
-2.93
Earnings Per Share (EPS)
-1.24
Revenue
31.25M
Net Profit
-88.48M

About Aclaris Therapeutics Inc

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from... Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.aclaristx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Aclaris Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ACRS. The last closing price for Aclaris Therapeutics was US$3.63. Over the last year, Aclaris Therapeutics shares have traded in a share price range of US$ 0.77 to US$ 5.17.

Aclaris Therapeutics currently has 71,430,942 shares in issue. The market capitalisation of Aclaris Therapeutics is US$259.29 million. Aclaris Therapeutics has a price to earnings ratio (PE ratio) of -2.93.

Ask ADVFN Intelligence (AI)

ACRS Latest News

More News

Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

WAYNE, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for...

14 hours ago
GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities

26 November 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

26 November 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

23 November 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

22 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 November 2024
Edgar (US Regulatory)

This Healthcare Stock Soared Following Exclusive License Agreement Announcement

A healthcare company based out of Pennsylvania caused quite the stir on Tuesday after the company announced that it had entered into an exclusive license agreement with Biosion To read the full...

20 November 2024
AllPennyStocks.com

Form 3 - Initial statement of beneficial ownership of securities

19 November 2024
Edgar (US Regulatory)

Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets

Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets PR Newswire NEWARK, Del. and NANJING, China...

19 November 2024
PR Newswire (US)

Form 8-K - Current report

19 November 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.81-18.24324324324.444.553.62530664183.9331142CS
41.95116.0714285711.685.171.6556769463.84735129CS
122.48215.6521739131.155.171.1222758943.50721769CS
262.48215.6521739131.155.170.951514348302.94852955CS
522.7987336.6654637320.83135.170.7715444641.96929973CS
156-9.29-71.904024767812.9218.95830.590211711704.84694969CS
2601.981201.6530.3750.590210479867.6072726CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HWHHWH International Inc
US$ 1.12
(98.23%)
7.16M
IFBDInfobird Company Ltd
US$ 2.77
(52.20%)
3.11M
CYCNCyclerion Therapeutics Inc
US$ 2.05
(50.74%)
6.6M
IDAIT Stamp Inc
US$ 0.5188
(42.14%)
10.28M
QMCOQuantum Corporation
US$ 23.66
(37.32%)
358.51k
PGHLPrimega Group Holdings Ltd
US$ 11.65
(-89.15%)
238.91k
WAVEEco Wave Power Global AB
US$ 6.50
(-44.01%)
2
IMGCIMG Inc
US$ 1.17
(-26.88%)
318.87k
SDOTSadot Group Inc
US$ 3.01
(-24.75%)
652
NVXNOVONIX Ltd
US$ 2.05
(-23.79%)
17.01k
IDAIT Stamp Inc
US$ 0.5188
(42.14%)
10.28M
HWHHWH International Inc
US$ 1.12
(98.23%)
7.16M
CYCNCyclerion Therapeutics Inc
US$ 2.05
(50.74%)
6.6M
DUOFangDD Network Group Ltd
US$ 0.6028
(13.31%)
5.21M
RGTIRigetti Computing Inc
US$ 2.43
(10.45%)
4.22M

ACRS Discussion

View Posts
glenn1919 glenn1919 2 days ago
ACRS.......................................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
retireat40 retireat40 1 week ago
May see $6 this week. 
👍️0
TrendTrade2016 TrendTrade2016 1 week ago
THATS TOP
👍️0
TrendTrade2016 TrendTrade2016 1 week ago
READY TO BREAK 5.00
👍️0
TrendTrade2016 TrendTrade2016 1 week ago
ACRS BIO BEAST BREAKING NEW HIGHS
👍️0
wesley_ wesley_ 1 week ago
$4+ weee
👍️0
TrendTrade2016 TrendTrade2016 1 week ago
ACRS MONSTER BIO
👍️0
wesley_ wesley_ 1 week ago
$3+
👍️0
glenn1919 glenn1919 1 week ago
ACRS...........https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 weeks ago
ACRS................................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
wesley_ wesley_ 3 weeks ago
$2.23 love it
👍️0
glenn1919 glenn1919 3 weeks ago
ACRS..............................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 4 weeks ago
ACRS.........................................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 4 weeks ago
ACRS.............................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
wesley_ wesley_ 4 weeks ago
nice set up
👍️0
glenn1919 glenn1919 4 months ago
ACRS.............https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
Awl416 Awl416 4 months ago
Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million
👍️0
Monksdream Monksdream 8 months ago
ACRS under $2
👍️0
glenn1919 glenn1919 9 months ago
ACRS..........................................https://stockcharts.com/h-sc/ui?s=ACRS&p=W&b=5&g=0&id=p86431144783
👍️0
Triple nickle Triple nickle 11 months ago
No worries here still adding.
👍️0
TheFinalCD TheFinalCD 12 months ago
ACRS The agreement includes an upfront payment of $15 million, regulatory and commercial milestones, and royalties
👍️0
81vette 81vette 12 months ago
7.4M short,1.5M available to short,fee 1%,rebate is 4.5% holy crap they pay you to short it,no wonder it’s shorted so much and beaten down,squeeze could be huge
👍️0
81vette 81vette 12 months ago
Could be interesting,beaten down,definitely run room
👍️0
TheFinalCD TheFinalCD 12 months ago
ACRS NEWS https://www.globenewswire.com/news-release/2023/12/05/2791335/37216/en/Aclaris-Therapeutics-Announces-Patent-License-Agreement-with-Sun-Pharma-for-Alopecia.html

https://finviz.com/quote.ashx?t=ACRS&p=d

https://dilutiontracker.com/app/search/ACRS


https://finance.yahoo.com/news/aclaris-acrs-loses-83-17-143502790.html
👍️0
Terpi Terpi 1 year ago
Shake and Bake
👍️0
Zorro Zorro 1 year ago
Way overdone. Shorter's paradise. Lol!
👍️0
Penny chatter Penny chatter 1 year ago
Thanks Clay
👍️0
Afterhoursearnings3 Afterhoursearnings3 1 year ago
Grabbed some here on the overreaction
👍️0
TimeFades TimeFades 1 year ago
In
👍️0
TheFinalCD TheFinalCD 1 year ago
ACRS.67 Aclaris Therapeutics to stop development of rheumatoid arthritis drug

https://finviz.com/quote.ashx?t=ACRS&ty=c&ta=1&p=d

https://dilutiontracker.com/app/search/ACRS?a=dbb88c
👍️0
alchemytrader alchemytrader 4 years ago
I was short premarket 20.30 then quickly covered 20.27 for scratch because she was still holding up.

Shes a scary on to short. ran to 24.00 at open before fading.

In hindsight, should have shorted 24.00 but was busy with other plays.
👍️0
SteevoTrader SteevoTrader 4 years ago
ACRS offering more than 5m shares at $17.50/per share
👍️0
alchemytrader alchemytrader 4 years ago
The way she kept grinding back to 19s could gap.

Who knows in this market. Robin Hood traders buy anything.
👍️0
SteevoTrader SteevoTrader 4 years ago
Are we seeing a dump tomorrow?
👍️0
alchemytrader alchemytrader 4 years ago
Oh really? hit 19.95 today...
👍️0
ClayTrader ClayTrader 4 years ago
* * $ACRS Video Chart 01-19-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
Marketwise Marketwise 4 years ago
One month later. Take a look now. E-trade certainly did you no favor.
👍️0
Docstemcell2020 Docstemcell2020 4 years ago
Nice!
👍️0
Serge521 Serge521 4 years ago
Im so happy Etrade wouldnt let me buy this couple of days ago..
I owe Etrade big
👍️0
interloper interloper 4 years ago
So ACRS trials will take 2 years but let’s rush a vaccine out by January 2021.
👍️0
DanSanTrades DanSanTrades 4 years ago
ACRS Trials gets an update from the FDA. Their now recruiting for the trial. Status updated over the weekend.

Clinical Trial Link
👍️0
ClayTrader ClayTrader 4 years ago
* * $ACRS Video Chart 07-20-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 4 years ago
* * $ACRS Video Chart 06-17-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
ClayTrader ClayTrader 5 years ago
* * $ACRS Video Chart 01-10-2020 * *

Link to Video - click here to watch the technical chart video

👍️0
beambe beambe 5 years ago
good Volume
👍️0
XenaLives XenaLives 5 years ago
Just a shout out here, anyone with fundamental DD on ACRS?

👍️0
jonny_red jonny_red 5 years ago
3 Penny Stocks To Watch As Biotech Hits New Highs

$ACRS $ISEE $ONCY

https://www.transparenttraders.me/2019/10/3-penny-stocks-to-watch-as-biotech-hits.html

👍️0
ClayTrader ClayTrader 5 years ago
* * $ACRS Video Chart 10-29-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
BottomBounce BottomBounce 5 years ago
$ACRS Overbought Aclaris Therapeutics (ACRS) May Report Negative Earnings
👍️0
jonny_red jonny_red 5 years ago
3 Best Penny Stocks To Trade Before Next Week?

$ATNM $CHK $ACRS

https://www.transparenttraders.me/2019/10/3-best-penny-stocks-to-trade-before.html
👍️0

Your Recent History

NASDAQ
ACRS
Aclaris Therapeutics
BIT
P19GE2
BNP Paribas Issuance
BIT
P1HBC0
BNP Paribas Issuance
BIT
P19732
BNP Paribas Issuance
BIT
P1U5Z3
BNP Paribas Issuance
BIT
RLT
Relatech
COIN
GENWUSD
Generational Wealth
BOV
BCIA11
Bradesco Real Estate Por...
BIT
CSP
CSP
TSXV
NBR
Nubian Resources
TSX
ECN.DB
Ecn Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36